Nicotine and caffeine Flashcards

1
Q

Describe nicotine

A
  • Acts as an agonist at the nicotinic
    acetylcholine receptor (NAChR)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Describe routes of administration

A
  • Available by oral (chewing tobacco), inhalation
    (cigarettes, cigars, and pipes), intranasal
    (insufflation – snuff), transdermal (patch)
  • Nicotine reaches the brain from the lungs ~ 7
    seconds after inhalation
  • Much faster than intravenous injection
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe brain areas affected by nicotine administration

A
  • High affinity NAChR found in
    ventral tegmental area
  • Peripheral receptors are found in the
    autonomic ganglia (sympathetic and
    parasympathetic)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Describe nicotine reinforcement

A

Cholinergic inputs to the ventral
tegmental area are responsible for
activating mesolimbic dopamine
neurons.

Nicotine activates NAChR on the
mesolimbic dopamine projections from
the VTA to the nucleus accumbens to
moderate nicotine’s reinforcing effects.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Describe nicotine’s effects in current smokers

A
  • Nicotine administration results in
    increased calmness and relaxation
  • Nicotine increases performance on
    cognitive tasks
  • Increases attention
  • Enhances mood
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe nicotine’s effects in non-smokers

A
  • Nicotine administration results in
    anxiety, heightened tension, light-
    headedness, dizziness, and nausea
  • Nicotine in high doses decreases
    reaction time
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe reaction time tests

A
  • Nicotine decreases reaction time in a
    trial requiring sustained visual attention.
  • Current smokers had a greater
    sensitivity to nicotine than did non-
    smokers (lower doses of nicotine effective
    at reducing reaction time).
  • Abstinent smokers had a longer
    reaction time than non-smokers –
    suggesting the stimulant effects of nicotine
    may at best compensate for a deficit.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe nicotine tolerance and dependence

A
  • Nicotine is well known to develop acute
    and chronic tolerance and dependence
  • Acute tolerance develops due to
    inactivation of NAChR
  • After first cigarette of the day nicotine
    remains high enough in blood to
    desensitize NAChR
  • Levels drop overnight or with several hours
    of abstinence
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe nicotine self-administration studies

A
  • Suggests adolescence is a particularly
    vulnerable period for development of
    addictions.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe what happens when nicotine poisoning is untreated

A

If untreated:
* Convulsions
* Respiratory failure due to depolarization block of
diaphragm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Describe some reasons why people smoke

A
  • Mood effects:
  • Chronic smoking decreases
    monoamine oxidase levels in the
    brain and periphery
  • Increased monoamines (DA, 5-HT, NE)
  • Antidepressant effects
  • Satiety:
  • Smoking supresses appetite
  • Weight gain common rebound effect of
    cessation
  • Many of the stimulant effects are
    proposed to act only to attenuate
    withdrawal-associated deficits
  • Withdrawal includes irritability,
    stress, poor concentration
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Describe caffeine characteristics

A
  • High absorption from oral doses
  • Stimulant and anxiogenic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is caffeine?

A
  • Caffeine is a xanthine
    alkyloid
  • Structurally analogous
    to the neuromodulator
    adenosine (nucleoside and neuromodulator)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe caffeine’s biphasic effects

A
  • Increased locomotion at low
    dose
  • Decreased locomotion at high
    dose
  • In blinded studies vs placebo
    caffeine increased alertness
    and decreased tension,
    decreased reaction times
  • In abstinent coffee drinkers
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe the therapeutic effects of caffeine

A
  • OTC analgesics
  • Caffeine has been shown
    effective at treatment for non-
    migraine headache
  • Apneic episodes in newborns
  • Periodic cessation of breathing,
    common in premature infants
  • Principal treatment is caffeine or
    theophylline
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Describe caffeine tolerance

A
  • Tolerance develops to some subjective effects of caffeine
  • Acute tolerance allows one to fall asleep after a late-night cup of coffee
  • Physiological and psychological symptoms of
    withdrawal:
  • Headache, lethargy, fatigue
  • Impaired psychomotor performance
  • Mild anxiety or depression
  • If abstinent withdrawal may last a few days before
    dissipating
17
Q

Describe caffeine dependence

A
  • Caffeine can excite the mesolimbic DA pathway but
    only at very high doses
  • 5-10 X above ‘normal’ doses
  • Well demonstrated but considered relatively harmless
  • Behavioural / psychological dependence (not
    pharmacological) plays a significant role in reinforcing
    effects of caffeine
  • Most chronic coffee drinking is to provide relief of
    withdrawal
18
Q

Describe biochemical effects of caffeine

A
  • Caffeine acts at many sites in the CNS
    including GABAA receptors and eliciting
    Ca2+
    -release within cells, but most likely
    exerts stimulant effects by antagonising
    adenosine receptors.
  • Adenosine is elevated in the cat brain
    after periods of long wakefulness (sleep
    deprivation) and is suggested to signal
    increased sleep pressure.
  • Blockade of adenosine receptors reduces
    drowsiness.
19
Q

Describe adenosine

A
  • Inhibitory at multiple sites in the
    hypothalamus
  • Suprachiasmic nuclei (SCN)
  • Lateral hypothalamus (LHA)
  • Preoptic areas (MnPO, VLPO)